Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?

Sara Appino, The Motley Fool

Thu, June 11, 2026 astatine 11:09 AM CDT 5 min read

Deciding betwixt high-growth healthcare players often involves choosing betwixt specialized surgical tools and innovative diligent therapies. Both Alphatec (NASDAQ:ATEC) and Inspire Medical Systems (NYSE:INSP) connection compelling opportunities for investors seeking aesculapian instrumentality exposure.

Alphatec specializes successful a full-stack attack to spine surgery, integrating imaging and surgical exertion to amended objective outcomes. Inspire focuses connected neurostimulation for obstructive slumber apnea, offering an alternate to accepted breathing machines. While some run successful the aesculapian exertion field, their fiscal profiles and marketplace maturity levels supply antithetic introduction points for retail investors.

The lawsuit for Alphatec

Alphatec operates arsenic a spine-focused exertion provider, processing precocious hardware and bundle solutions for analyzable surgical procedures. It differentiates itself done an integrated ecosystem, utilizing subsidiaries similar EOS imaging and SafeOp Surgical to enactment surgeons done the full objective workflow. The institution chiefly serves the U.S. infirmary marketplace but is actively expanding its planetary footprint successful Europe and Japan to scope a broader diligent base.

In FY 2025, gross reached astir $764.2 million, representing a important 25.0% summation implicit the anterior twelvemonth arsenic adoption of its spine solutions grew. Despite this top-line momentum, the institution reported a nett nonaccomplishment of astir $143.4 cardinal for the period. The nett margin, which measures the percent of gross remaining aft each expenses, improved to antagonistic 18.8% from antagonistic 26.5% during the erstwhile fiscal year.

As of its December 2025 equilibrium sheet, the debt-to-equity ratio is astir 17.2x, meaning full indebtedness is overmuch higher than shareholder equity. The existent ratio, which measures the quality to wage short-term debts with short-term assets, is astir 2.1x. Note that stock-based compensation represented astir 163.0% of operating currency flow, meaning reported currency procreation is heavy inflated by this non-cash add-back.

The lawsuit for Inspire Medical Systems

Inspire Medical Systems provides a unsocial neurostimulation therapy for patients with obstructive slumber apnea who cannot tolerate modular continuous affirmative airway unit treatments. The institution focuses connected its proprietary Inspire system, targeting slumber specialists and ear, nose, and pharynx surgeons crossed planetary markets. By addressing an underserved population, the institution has established a starring presumption among medical instrumentality stocks specializing successful precocious respiratory care.